Invesco’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17B Buy
18,296,350
+992,911
+6% +$65.3M 0.09% 155
2026
Q1
$1.23B Buy
17,303,439
+66,403
+0.4% +$5.24M 0.12% 139
2025
Q4
$1.41B Buy
17,237,036
+10,345,892
+150% +$806M 0.13% 122
2025
Q3
$518M Sell
6,891,144
-1,022,807
-13% -$76.3M 0.08% 283
2025
Q2
$586M Sell
7,913,951
-64,090
-0.8% -$4.46M 0.1% 232
2025
Q1
$644M Sell
7,978,041
-89,886
-1% -$7.72M 0.12% 189
2024
Q4
$631M Buy
8,067,927
+1,252,613
+18% +$106M 0.12% 193
2024
Q3
$640M Buy
6,815,314
+825,766
+14% +$69.3M 0.12% 182
2024
Q2
$467M Buy
5,989,548
+1,253,020
+26% +$102M 0.1% 242
2024
Q1
$431M Sell
4,736,528
-654,771
-12% -$54.5M 0.09% 274
2023
Q4
$417M Buy
5,391,299
+343,037
+7% +$24M 0.1% 260
2023
Q3
$343M Buy
5,048,262
+889,297
+21% +$64.7M 0.09% 278
2023
Q2
$338M Buy
4,158,965
+985,256
+31% +$78.6M 0.09% 295
2023
Q1
$260M Buy
+3,173,709
New +$227M 0.07% 367

Other funds holding GEHC

Invesco's GEHC Position: Q2 2026 in Review

Invesco increased its GE HealthCare (GEHC) stake by 5.7% in Q2 2026, buying an estimated $65.3M and bringing the position to 18,296,350 shares worth $1.17B. The position accounts for 0.09% of the portfolio, ranked #155.

Invesco first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.41B in Q4 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Invesco held 18,296,350 shares of GE HealthCare worth $1.17B as of Q2 2026.
  • Invesco bought 992,911 GE HealthCare shares in Q2 2026, an estimated $65.3M.
  • GE HealthCare made up 0.09% of Invesco's portfolio in Q2 2026, its #155 holding.
  • Invesco first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Invesco's GE HealthCare position peaked at $1.41B in Q4 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.